Understanding the molecular basis of cardiac ion channels allows for the development of targeted antiarrhythmic drugs with specific channel-blocking profiles to minimize proarrhythmia.
No takes yet. Share an insight, caveat, or question.
May favor dual IKr/IKs blockers like amiodarone to limit torsades risk; leaves open targeted development of selective agents.
Stanley Nattel (1999) studied this question.